Atlas Trials

Study of Eribulin in Children With Cancer to Determine Safety

Clinical trial NCT02082626 · TERMINATED

Trial details

NCT number
NCT02082626
Sponsor
University of Oklahoma
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Pediatric CancerSolid TumorsLymphoma
Start date
2014-02-01
Primary completion
2018-06-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.